Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #501 to #550.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Emergency‏‎ (2 revisions)
  2. Latent time/period or latency interval‏‎ (2 revisions)
  3. Low level waste‏‎ (2 revisions)
  4. Exposure, external or internal‏‎ (2 revisions)
  5. Graft vs host disease‏‎ (2 revisions)
  6. Air-kerma, incident‏‎ (2 revisions)
  7. Heliosphere‏‎ (2 revisions)
  8. Qualified expert‏‎ (2 revisions)
  9. Class SR-0 gases‏‎ (2 revisions)
  10. Radioactive substance‏‎ (2 revisions)
  11. Reference biokinetic model‏‎ (2 revisions)
  12. Decontamination‏‎ (2 revisions)
  13. Relocation‏‎ (2 revisions)
  14. Diastasis‏‎ (2 revisions)
  15. Risk coefficient‏‎ (2 revisions)
  16. Individual monitoring‏‎ (2 revisions)
  17. Dose rate‏‎ (2 revisions)
  18. Intervention Level‏‎ (2 revisions)
  19. Emergency exposure situation‏‎ (2 revisions)
  20. Substantial radiation dose level‏‎ (2 revisions)
  21. Erythropoietin‏‎ (2 revisions)
  22. Exposure (in the context of inhalation)‏‎ (2 revisions)
  23. Transfer rate‏‎ (2 revisions)
  24. Multi-detector computed tomography‏‎ (2 revisions)
  25. Fractionation and dose delivery patterns‏‎ (2 revisions)
  26. Percutaneous coronary intervention‏‎ (2 revisions)
  27. Prevailing circumstances‏‎ (2 revisions)
  28. Broad beam therapy irradiation technique‏‎ (2 revisions)
  29. Class SR-1 gases‏‎ (2 revisions)
  30. Committed effective dose‏‎ (2 revisions)
  31. Radon Recommendations for Authorities‏‎ (2 revisions)
  32. Cost-benefit analysis‏‎ (2 revisions)
  33. Reference individual‏‎ (2 revisions)
  34. Decontamination factor‏‎ (2 revisions)
  35. Remedial action‏‎ (2 revisions)
  36. ICRPædia Guide to Dose Coefficients‏‎ (2 revisions)
  37. Dose rate effectiveness factor‏‎ (2 revisions)
  38. South Atlantic anomaly‏‎ (2 revisions)
  39. Interventional procedure‏‎ (2 revisions)
  40. Emergency plan‏‎ (2 revisions)
  41. Ethics‏‎ (2 revisions)
  42. Lymphatic system‏‎ (2 revisions)
  43. ALARA‏‎ (2 revisions)
  44. Transforming growth factor‏‎ (2 revisions)
  45. Hierarchical tissues‏‎ (2 revisions)
  46. Area monitoring‏‎ (2 revisions)
  47. Pericarditis‏‎ (2 revisions)
  48. Benthic‏‎ (2 revisions)
  49. Principle of application of dose limits‏‎ (2 revisions)
  50. Bronchial region‏‎ (2 revisions)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)